Listed

Akso Health Group

AHGNasdaqCIK 1702318IndustrialsFiscal year ends Mar 31

Revenue is not reported in this company’s XBRL financial statements.

Latest quarter: not reported

Last eight quarters

Full statements
Akso Health Group, key figures for the last eight quarters
Line itemUnitShape over the periods
Revenue$
Gross margin%
Operating margin%
Net margin%
Diluted EPS$ per share
Free cash flow$

Focus or hover a figure to see its XBRL concept, period and filing; each links to that filing. A figure marked d is derived: a quarter computed from year-to-date figures, such as the fourth quarter as the fiscal year less the nine months before it. A ratio reads not reported when any input is missing.

Last five fiscal years

Revenue$13.8mGross margin −0.1%
Diluted EPS$0.01, FY2026
Free cash flow−$12.8m, FY2026
Akso Health Group, key figures for the last five fiscal years
Line itemUnitFY20222022-03-31FY20232023-03-31FY20242024-03-31FY20252025-03-31FY20262026-03-31Shape over the periods
Revenue$m6.3Revenue, FY2022, twelve months to 2022-03-31$6.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 20-F filed 2022-12-29, accession 0001104659-22-130935.Report this figure13.2Revenue, FY2023, twelve months to 2023-03-31$13.2m. XBRL concept us-gaap:Revenues. 20-F filed 2025-08-14, accession 0001213900-25-076862.Report this figure2.4Revenue, FY2024, twelve months to 2024-03-31$2.4m. XBRL concept us-gaap:Revenues. 20-F filed 2026-07-23, accession 0001213900-26-080868.Report this figure14.8Revenue, FY2025, twelve months to 2025-03-31$14.8m. XBRL concept us-gaap:Revenues. 20-F filed 2026-07-23, accession 0001213900-26-080868.Report this figure13.8Revenue, FY2026, twelve months to 2026-03-31$13.8m. XBRL concept us-gaap:Revenues. 20-F filed 2026-07-23, accession 0001213900-26-080868.Report this figure
Gross margin%9.6%Gross margin, FY2022, twelve months to 2022-03-31. gross profit / revenueGross profit: $605.1k. XBRL concept us-gaap:GrossProfit. 20-F filed 2024-07-30, accession 0001013762-24-002658.Revenue: $6.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 20-F filed 2022-12-29, accession 0001104659-22-130935.Report this figure9.6%Gross margin, FY2023, twelve months to 2023-03-31. gross profit / revenueGross profit: $1.3m. XBRL concept us-gaap:GrossProfit. 20-F filed 2025-08-14, accession 0001213900-25-076862.Revenue: $13.2m. XBRL concept us-gaap:Revenues. 20-F filed 2025-08-14, accession 0001213900-25-076862.Report this figure5.1%Gross margin, FY2024, twelve months to 2024-03-31. gross profit / revenueGross profit: $122.1k. XBRL concept us-gaap:GrossProfit. 20-F filed 2026-07-23, accession 0001213900-26-080868.Revenue: $2.4m. XBRL concept us-gaap:Revenues. 20-F filed 2026-07-23, accession 0001213900-26-080868.Report this figure(1.9%)Gross margin, FY2025, twelve months to 2025-03-31. gross profit / revenueGross profit: −$281.5k. XBRL concept us-gaap:GrossProfit. 20-F filed 2026-07-23, accession 0001213900-26-080868.Revenue: $14.8m. XBRL concept us-gaap:Revenues. 20-F filed 2026-07-23, accession 0001213900-26-080868.Report this figure(0.1%)Gross margin, FY2026, twelve months to 2026-03-31. gross profit / revenueGross profit: −$11.3k. XBRL concept us-gaap:GrossProfit. 20-F filed 2026-07-23, accession 0001213900-26-080868.Revenue: $13.8m. XBRL concept us-gaap:Revenues. 20-F filed 2026-07-23, accession 0001213900-26-080868.Report this figure
Operating margin%(51.7%)Operating margin, FY2022, twelve months to 2022-03-31. operating income / revenueOperating income: −$3.3m. XBRL concept us-gaap:OperatingIncomeLoss. 20-F filed 2024-07-30, accession 0001013762-24-002658.Revenue: $6.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 20-F filed 2022-12-29, accession 0001104659-22-130935.Report this figure(108.2%)Operating margin, FY2023, twelve months to 2023-03-31. operating income / revenueOperating income: −$14.3m. XBRL concept us-gaap:OperatingIncomeLoss. 20-F filed 2025-08-14, accession 0001213900-25-076862.Revenue: $13.2m. XBRL concept us-gaap:Revenues. 20-F filed 2025-08-14, accession 0001213900-25-076862.Report this figure(357.8%)Operating margin, FY2024, twelve months to 2024-03-31. operating income / revenueOperating income: −$8.6m. XBRL concept us-gaap:OperatingIncomeLoss. 20-F filed 2026-07-23, accession 0001213900-26-080868.Revenue: $2.4m. XBRL concept us-gaap:Revenues. 20-F filed 2026-07-23, accession 0001213900-26-080868.Report this figure(1125.4%)Operating margin, FY2025, twelve months to 2025-03-31. operating income / revenueOperating income: −$166.3m. XBRL concept us-gaap:OperatingIncomeLoss. 20-F filed 2026-07-23, accession 0001213900-26-080868.Revenue: $14.8m. XBRL concept us-gaap:Revenues. 20-F filed 2026-07-23, accession 0001213900-26-080868.Report this figure(149.7%)Operating margin, FY2026, twelve months to 2026-03-31. operating income / revenueOperating income: −$20.7m. XBRL concept us-gaap:OperatingIncomeLoss. 20-F filed 2026-07-23, accession 0001213900-26-080868.Revenue: $13.8m. XBRL concept us-gaap:Revenues. 20-F filed 2026-07-23, accession 0001213900-26-080868.Report this figure
Net margin%(267.0%)Net margin, FY2022, twelve months to 2022-03-31. net income / revenueNet income: −$16.9m. XBRL concept us-gaap:NetIncomeLoss. 20-F filed 2024-07-30, accession 0001013762-24-002658.Revenue: $6.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 20-F filed 2022-12-29, accession 0001104659-22-130935.Report this figure(10.3%)Net margin, FY2023, twelve months to 2023-03-31. net income / revenueNet income: −$1.4m. XBRL concept us-gaap:NetIncomeLoss. 20-F filed 2025-08-14, accession 0001213900-25-076862.Revenue: $13.2m. XBRL concept us-gaap:Revenues. 20-F filed 2025-08-14, accession 0001213900-25-076862.Report this figure(391.8%)Net margin, FY2024, twelve months to 2024-03-31. net income / revenueNet income: −$9.5m. XBRL concept us-gaap:NetIncomeLoss. 20-F filed 2026-07-23, accession 0001213900-26-080868.Revenue: $2.4m. XBRL concept us-gaap:Revenues. 20-F filed 2026-07-23, accession 0001213900-26-080868.Report this figure(913.4%)Net margin, FY2025, twelve months to 2025-03-31. net income / revenueNet income: −$135.0m. XBRL concept us-gaap:NetIncomeLoss. 20-F filed 2026-07-23, accession 0001213900-26-080868.Revenue: $14.8m. XBRL concept us-gaap:Revenues. 20-F filed 2026-07-23, accession 0001213900-26-080868.Report this figure(135.0%)Net margin, FY2026, twelve months to 2026-03-31. net income / revenueNet income: −$18.7m. XBRL concept us-gaap:NetIncomeLoss. 20-F filed 2026-07-23, accession 0001213900-26-080868.Revenue: $13.8m. XBRL concept us-gaap:Revenues. 20-F filed 2026-07-23, accession 0001213900-26-080868.Report this figure
Diluted EPS$ per share(0.28)Diluted EPS, FY2022, twelve months to 2022-03-31−$0.28 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 20-F filed 2024-07-30, accession 0001013762-24-002658.Report this figure(0.02)Diluted EPS, FY2023, twelve months to 2023-03-31−$0.02 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 20-F filed 2025-08-14, accession 0001213900-25-076862.Report this figure0.07Diluted EPS, FY2024, twelve months to 2024-03-31$0.07 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 20-F filed 2026-07-23, accession 0001213900-26-080868.Report this figure0.16Diluted EPS, FY2025, twelve months to 2025-03-31$0.16 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 20-F filed 2026-07-23, accession 0001213900-26-080868.Report this figure0.01Diluted EPS, FY2026, twelve months to 2026-03-31$0.01 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 20-F filed 2026-07-23, accession 0001213900-26-080868.Report this figure
Free cash flow$m(8.6)Free cash flow, FY2022, twelve months to 2022-03-31. operating cash flow − capital expenditureOperating cash flow: −$8.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 20-F filed 2024-07-30, accession 0001013762-24-002658.Capital expenditure: $4.9k. XBRL concept us-gaap:PaymentsToAcquireProductiveAssets. 20-F filed 2022-12-29, accession 0001104659-22-130935.Report this figurenot reported (Capital expenditure not reported)not reported (Capital expenditure not reported)1.0Free cash flow, FY2025, twelve months to 2025-03-31. operating cash flow − capital expenditureOperating cash flow: $1.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 20-F filed 2026-07-23, accession 0001213900-26-080868.Capital expenditure: $154.5k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 20-F filed 2026-07-23, accession 0001213900-26-080868.Report this figure(12.8)Free cash flow, FY2026, twelve months to 2026-03-31. operating cash flow − capital expenditureOperating cash flow: −$12.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 20-F filed 2026-07-23, accession 0001213900-26-080868.Capital expenditure: $1.6k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 20-F filed 2026-07-23, accession 0001213900-26-080868.Report this figure

Focus or hover a figure to see its XBRL concept, period and filing; each links to that filing. A figure marked d is derived: a quarter computed from year-to-date figures, such as the fourth quarter as the fiscal year less the nine months before it. A ratio reads not reported when any input is missing.

Insider purchases and sales

All insider transactions

The last 20 open-market transactions reported on Form 4 (codes P and S). The reported price is the price per share the insider stated on the form: filing data, not a market price.

No open-market purchases or sales by insiders are in coverage from Nov 2024 to Oct 2026.

No open-market purchases or sales by insiders are in coverage for this company.

Funds that report holding it

All funds

From each manager's latest Form 13F, largest reported value first. Reported value is as filed at the quarter end: filing data, not a price. A put or call is an option position, not shares held.

Funds that report holding Akso Health Group
FundQuarter endedReported valueSharesPut or callChange on the quarter before
RENAISSANCE TECHNOLOGIES LLC2026-06-30$105.7k70,943Reduced−27,455
NORTHERN TRUST CORP2026-06-30$76.6k51,403Added+4,528
CITADEL ADVISORS LLC2026-06-30$68.6k46,026New+46,026
SmartHarvest Portfolios, LLC2026-06-30$66.7k44,755Added+9,326
JANE STREET GROUP, LLC2026-06-30$61.6k41,360Added+10,123
GEODE CAPITAL MANAGEMENT, LLC2026-06-30$22.3k14,973Unchanged
BlackRock, Inc.2026-06-30$15.0k10,064Added+10,027
UBS Group AG2026-06-30$1.4k963New+963
MORGAN STANLEY2026-06-30$1.1k739New+739
HUNTINGTON NATIONAL BANK2026-06-30$624419New+419

Recent filings

All 192 filings

Reports and events: 10-K, 10-Q, 8-K, proxy statements and ownership schedules.

Akso Health Group, recent filings
FiledFormWhat it isAccession number
2026-07-2316:05 ET20-FAnnual report of a foreign private issuerPeriod 2026-03-310001213900-26-080868
2026-05-1316:14 ET6-KReport of a foreign private issuerPeriod 2026-05-130001213900-26-055807
2026-03-2316:40 ET6-KReport of a foreign private issuerPeriod 2026-03-230001213900-26-032967
2026-02-1016:06 ET6-KReport of a foreign private issuerPeriod 2025-09-300001213900-26-014261
2025-08-1417:29 ET20-FAnnual report of a foreign private issuerPeriod 2025-03-310001213900-25-076862
2025-05-0116:35 ET6-KReport of a foreign private issuerPeriod 2025-05-010001213900-25-038488
2025-03-2816:05 ET6-KReport of a foreign private issuerPeriod 2024-09-300001013762-25-004071
2024-11-0816:05 ET6-KReport of a foreign private issuerPeriod 2024-11-080001213900-24-095891
2024-07-3016:05 ET20-FAnnual report of a foreign private issuerPeriod 2024-03-310001013762-24-002658
2024-05-0208:00 ET6-KReport of a foreign private issuerPeriod 2024-05-020001213900-24-038753

Latest annual report

Form 20-F for the fiscal year ended Mar 31, 2026Filed Jul 23, 2026. Its page lists the documents and the extracted sections, such as Business and Risk factors.

Forecast league

Not in this season’s league. The league lists companies whose quarter has ended and whose results are not yet filed.This season’s league

About the filer

CIK
1702318
Tickers
AHG
Exchange
Nasdaq
SIC code
7389 Services-Business Services, NEC
Sector
Industrials
Fiscal year ends
Mar 31
Incorporated in
E9
Filer category
Large accelerated filer
Former names
Xiaobai Maimai Inc. (to 2021-12-17); Hexindai Inc. (to 2020-12-21)

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:46 ET. Listed shows no prices and gives no investment advice.